Alignment Healthcare, Inc.
ALHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $993,695 | $1,015,288 | $926,932 | $701,241 |
| % Growth | -2.1% | 9.5% | 32.2% | – |
| Cost of Goods Sold | $868,022 | $881,740 | $820,900 | $614,896 |
| Gross Profit | $125,673 | $133,548 | $106,032 | $86,345 |
| % Margin | 12.6% | 13.2% | 11.4% | 12.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $95,069 |
| SG&A Expenses | $110,015 | $103,797 | $103,831 | $100,825 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $5,756 |
| Other Operating Expenses | $7,977 | $7,003 | $7,594 | $8,065 |
| Operating Expenses | $117,992 | $110,800 | $111,425 | $108,890 |
| Operating Income | $7,681 | $22,748 | -$5,393 | -$22,545 |
| % Margin | 0.8% | 2.2% | -0.6% | -3.2% |
| Other Income/Exp. Net | -$3,950 | -$3,871 | -$3,940 | -$8,512 |
| Pre-Tax Income | $3,731 | $18,877 | -$9,333 | -$31,057 |
| Tax Expense | $2 | $3,224 | $21 | $7 |
| Net Income | $3,729 | $15,667 | -$9,114 | -$31,091 |
| % Margin | 0.4% | 1.5% | -1% | -4.4% |
| EPS | 0.019 | 0.079 | -0.047 | -0.16 |
| % Growth | -76.3% | 267.7% | 70.6% | – |
| EPS Diluted | 0.018 | 0.075 | -0.047 | -0.16 |
| Weighted Avg Shares Out | 199,027 | 198,329 | 193,606 | 191,897 |
| Weighted Avg Shares Out Dil | 208,928 | 209,520 | 193,606 | 191,897 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,950 | $3,950 | $3,950 | $5,492 |
| Depreciation & Amortization | $7,985 | $7,036 | $7,627 | $6,808 |
| EBITDA | $15,666 | $29,863 | $2,244 | -$18,757 |
| % Margin | 1.6% | 2.9% | 0.2% | -2.7% |